4-Bromo-1-chloro-2-(4-ethoxy-benzyl)-benzene

These drugs are inhibitors of the sodium-glucose co-transporter type 2 (SGLT2) and are used to help manage blood glucose levels in people with type 2 diabetes. This compound is crucial for the development and production of these active pharmaceutical ingredients (APIs) in both research and large-scale manufacturing settings. 4-Bromo-1-chloro-2-(4-ethoxy-benzyl)-benzene serves as a key intermediate in the synthesis of pharmaceutical drugs, specifically the antidiabetic medications Dapagliflozin and Empagliflozin.